Why the study?
Does carotid endarterectomy provide cost-effective stroke prevention compared to medical management from a public health perspective?
Does carotid endarterectomy provide cost-effective stroke prevention compared to medical management from a public health perspective?
From a public health perspective, the widespread use of carotid endarterectomy may be limited by its high cost, narrow target population, and questionable cost-effectiveness in asymptomatic patients.
Answers are grounded in this paper and cite their sources.
Limits enthusiasm for carotid endarterectomy in population stroke prevention; leaves open updated cost-effectiveness trials versus modern medical therapy.
Despite the completion of several multi-center clinical trials comparing medical management and carotid endarterectomy, there is still controversy as to when carotid endarterectomy is appropriate. The volume of this surgery appears to be increasing. However, available performance data indicate that the surgical proficiency required for the clinical trials is not achieved uniformly in actual practice. Therefore, benefits of carotid endarterectomy, when considered from a public health perspective, are limited by the following: (1) endarterectomy is an expensive stroke prevention modality; (2) endarterectomy addresses the needs of only a relatively small subset of stroke patients, and (3) endarterectomy for asymptomatic patients, without clearer evidence that these individuals benefit, may decrease the cost-effectiveness of this surgical procedure.
No takes yet. Share an insight, caveat, or question.
Seemant Chaturvedi (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: